Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics
- DOI
- 10.1136/bmjgast-2026-002343
- Published
- 2026-07
- Container
- BMJ Open Gastroenterology
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjgast-2026-002343,
title = {Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics},
author = {Fuliang Li and Hongmei Li and Dulguun Juramt and Kai Kou and Frank Tacke and Lanlan Chen},
year = {2026},
journal = {BMJ Open Gastroenterology},
doi = {10.1136/bmjgast-2026-002343},
url = {https://doi.org/10.1136/bmjgast-2026-002343}
}RIS
TY - JOUR TI - Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics AU - Fuliang Li AU - Hongmei Li AU - Dulguun Juramt AU - Kai Kou AU - Frank Tacke AU - Lanlan Chen PY - 2026 JO - BMJ Open Gastroenterology DO - 10.1136/bmjgast-2026-002343 UR - https://doi.org/10.1136/bmjgast-2026-002343 ER -
APA
Li, F., Li, H., Juramt, D., Kou, K., Tacke, F., & Chen, L. (2026). Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics. BMJ Open Gastroenterology. https://doi.org/10.1136/bmjgast-2026-002343
Source records
- crossref · retrieved 2026-09-26T11:24:35.400Z